Recent Advances in Pancreatic Neoplasms: Part II

Dear Colleagues,

It is my pleasure to invite you and members of your research group to submit an article for a Special Issue titled "Recent Advances in Pancreatic Neoplasms: Part II". This volume follows on from the previous one, in which more than 14 papers were published. For more details about the Special Issue, please visit: https://www.mdpi.com/journal/jcm/special_issues/Pancreatic_Neoplasms

Pancreatic cancer is the fourth leading cause of cancer death in Western countries, and will soon become the second leading cause of gastrointestinal cancer death. Surgery and adjuvant therapy remains the standard treatment, but the recurrence rate remains high. Multimodality treatment, that is, neoadjuvant therapy and a combination of chemotherapy, radiotherapy, immunotherapy, and surgery, appears to be essential to obtain better results, but definitive conclusions on its effectiveness are lacking. There is a need for an improved understanding of genetic alterations, clarification of the role of new biomarkers for precursor and invasive tumors, the identification of prognostic factors (i.e., nutritional, immunological, and surgical complications), and the management of recurrent cancer via tailored therapy. Furthermore, neuroendocrine tumors, including a variety of neoplasms with varying biological behaviors and treatments, are increasingly diagnosed in clinical practice. In particular, the management of small non-functioning tumors is still controversial, while the treatment of advanced disease requires novel research strategies. This Special Issue is focused on the latest developments and challenges in multimodality therapy for resectable and locally advanced pancreatic tumors, the search for prognostic factors for early and late outcomes after therapy, and the evaluation of novel strategies for individualized treatment. We invite relevant original research, systematic reviews, meta-analyses, and short communications covering the above-mentioned topics. 

Prof. Dr. Cosimo Sperti
Dr. Domenico Bassi
Dr. Simone Serafini
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.